Tokyo, July 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058425) titled 'Study on the failure to achieve the target LDL cholesterol level in patients with dyslipidaemia' on July 10.

Study Type: Observational

Primary Sponsor: Institute - Otsuka Pharmaceutical Co., Ltd.

Condition: Condition - Dyslipidaemia Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The target LDL-C non-achievement rate and its actual situation will be clarified for each risk category defined based on JAS GL2022. Basic objectives2 - Others

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Patients aged 18 years or older with dyslipidaemia who have LDL-C test results between 1 August 2022 and 31 March 2024. Key exclusion criteria - N/A Target Size - 200000

Recruitment Status: Recruitment status - No longer recruiting Date of protocol fixation - 2025 Year 03 Month 26 Day Date of IRB - 2025 Year 04 Month 16 Day Anticipated trial start date - 2025 Year 04 Month 16 Day Last follow-up date - 2025 Year 07 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066250

Disclaimer: Curated by HT Syndication.